Xing Xie
1 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| Fuzuloparib Arsenic Trioxide Platinum Resistance Relapsed Ovarian Cancer (NCT04518501) | Xing Xie | 2020-07-01 |
Track Xing Xie automatically
Every clearance here is in the API, with alerts when new ones post.